Log In
Print
BCIQ
Print
Print this Print this
 

Arbaclofen placarbil (AP) (XP19986) (formerly XP19986 SR3)

  Manage Alerts
Collapse Summary General Information
Company XenoPort Inc.
DescriptionTransported prodrug of R-baclofen, a GABA B receptor agonist
Molecular Target GABA B receptor
Mechanism of ActionGABA B receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAddiction
Indication DetailsTreat alcohol use disorder
Regulatory Designation
Partner Indivior plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$145.0M

$20.0M

$120.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today